Literature DB >> 17259598

ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia.

Xuebing Feng1, Hongyun Li, Alexis A Rumbin, Xuping Wang, Antonio La Cava, Katherine Brechtelsbauer, Lawrence W Castellani, Joseph L Witztum, Aldons J Lusis, Betty P Tsao.   

Abstract

To establish a mouse model of accelerated atherosclerosis in lupus, we generated apolipoprotein E-deficient (apoE(-/-)) and Fas(lpr/lpr) (Fas(-/-)) C57BL/6 mice. On a normal chow diet, 5 month old apoE(-/-)Fas(-/-) mice had enlarged glomerular tuft areas, severe proteinuria, increased circulating autoantibody levels, and increased apoptotic cells in renal and vascular lesions compared with either single knockout mice. Also, double knockout mice developed increased atherosclerotic lesions but decreased serum levels of total and non-HDL cholesterol compared with apoE(-/-)Fas(+/+) littermates. Moreover, female apoE(-/-)Fas(-/-) mice had lower vertebral bone mineral density (BMD) and bone volume density (BV/TV) than age-matched female apoE(-/-)Fas(+/+) mice. Compared with apoE(-/-)Fas(+/+) and apoE(+/+)Fas(-/-) mice, apoE(-/-)Fas(-/-) mice had decreased circulating oxidized phospholipid (OxPL) content on apoB-100 containing lipoprotein particles and increased serum IgG antibodies to OxPL, which were significantly correlated with aortic lesion areas (r = 0.58), glomerular tuft areas (r = 0.87), BMD (r = -0.57), and BV/TV (r = -0.72). These results suggest that the apoE(-/-)Fas(-/-) mouse model might be used to study atherosclerosis and osteopenia in lupus. Correlations of IgG anti-OxPL with lupus-like disease, atherosclerosis, and bone loss suggested a shared pathway of these disease processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259598     DOI: 10.1194/jlr.M600512-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  34 in total

1.  Markers of adipose tissue macrophage content are negatively associated with serum HDL-C concentrations.

Authors:  Jianying He; Xiaoyuan Xu; Ann Francisco; Anthony Ferrante; Jonathan Krakoff
Journal:  Atherosclerosis       Date:  2010-12-23       Impact factor: 5.162

Review 2.  Genetic basis of atherosclerosis: insights from mice and humans.

Authors:  Ioannis M Stylianou; Robert C Bauer; Muredach P Reilly; Daniel J Rader
Journal:  Circ Res       Date:  2012-01-20       Impact factor: 17.367

3.  The Role of Efferocytosis in Atherosclerosis.

Authors:  Yoko Kojima; Irving L Weissman; Nicholas J Leeper
Journal:  Circulation       Date:  2017-01-31       Impact factor: 29.690

4.  Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.

Authors:  Iryna Voloshyna; Isaac Teboul; Michael J Littlefield; Nicolle M Siegart; George K Turi; Melissa J Fazzari; Steven E Carsons; Joshua DeLeon; Allison B Reiss
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-27

5.  Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus.

Authors:  Yoko Kidani; Steven J Bensinger
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

Review 6.  High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.

Authors:  S-H Wang; S-G Yuan; D-Q Peng; S-P Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-06       Impact factor: 4.330

7.  Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.

Authors:  Jennifer M P Woo; Zhuofeng Lin; Mohamad Navab; Casey Van Dyck; Yvette Trejo-Lopez; Krystal M T Woo; Hongyun Li; Lawrence W Castellani; Xuping Wang; Noriko Iikuni; Ornella J Rullo; Hui Wu; Antonio La Cava; Alan M Fogelman; Aldons J Lusis; Betty P Tsao
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

8.  Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.

Authors:  Ashley J Wilhelm; Manal Zabalawi; Jason M Grayson; Ashley E Weant; Amy S Major; John Owen; Manish Bharadwaj; Rosemary Walzem; Lawrence Chan; Kazuhiro Oka; Michael J Thomas; Mary G Sorci-Thomas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-12       Impact factor: 8.311

Review 9.  Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity.

Authors:  Yoko Kidani; Steven J Bensinger
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

10.  Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice.

Authors:  Kerry W S Ko; David B Corry; Cory F Brayton; Antoni Paul; Lawrence Chan
Journal:  Biochem Biophys Res Commun       Date:  2009-04-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.